Search results

...cause it. Leukopenia is common as a result of cancer chemotherapy with [[antineoplastic agent]]s.

{{r|Antineoplastic agent}}

{{r|Antineoplastic agent}}

{{r|Antineoplastic agent}}

{{r|Antineoplastic agent}}

{{r|Antineoplastic agent}}

...es]]}}</ref>. It also, however, has been a starting point for developing [[antineoplastic agent]]s, especially the [[anthracycline]] agents, of which [[doxorubricin]] (Adr

...are present in traditional herbal medicines, and are being researched as [[antineoplastic agent]]s.

In [[oncology]], '''carboplatin''' is a [[antineoplastic agent]] that is an "organoplatinum compound that possesses antineoplastic activit

* [[mercaptopurine]] is an "antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesi ...ally acute non-lymphoblastic [[leukemia]]. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phas

...Sloan-Kettering Cancer Center]], no studies of sheep sorrel alone, as an antineoplastic agent, have been done.

{{r|Antineoplastic agent}}

...etabolite fluoropyrimidine analog of the nucleoside pyrimidine, used as an antineoplastic agent but also as an immunomodulator in dermatology.

In [[medicine]], '''cetuximab''' (se tux' i mab) is an [[antineoplastic agent]] that is "an [[antibody]] that blocks [[epidermal growth factor receptor|r

...vastin''' by [[Genentech]], a subsidiary of [[Roche Laboratories]] as an [[antineoplastic agent]].

...relatively low prevalence of the disease, there is less experience with [[antineoplastic agent]]s and [[biologic response modifier]]s. More successful chemotherapy has us

As a primary [[antineoplastic agent]], [[fludarabine]] may be more effective than [[chlorambucil]].<ref name="p

...d of the war, they proved to be the basis of some of the first effective [[antineoplastic agent]]s for [[cancer]] [[chemotherapy]].

Bleomycin and carboplatin are the most common adjuvant and palliative [[antineoplastic agent]]s. As with any cancer chemotherapy, the challenge is managing the toxicity

'''⁹⁰Yttrium-Ibritumomab Tiuxetan''' is an [[antineoplastic agent]] indicated for [[non-Hodgkin’s lymphom]]a. ⁹⁰Y-Ibritumomab Ti

*[[Antineoplastic agent/Definition]]